RPL17 and pulmonary fibrosis: Interestingly, blockading the PD-1 pathway significantly decreased STAT3, IL-17A, and TGF-β expression levels on Th17 cells, subsequently reducing collagen I production from fibroblasts and attenuating lung fibrosis in a murine model.